help button home button
AJRCCM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by WELSH, D. J.
Right arrow Articles by HARNETT, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by WELSH, D. J.
Right arrow Articles by HARNETT, M.

Am. J. Respir. Crit. Care Med., Volume 164, Number 2, July 2001, 282-289

Chronic Hypoxia Induces Constitutive p38 Mitogen-activated Protein Kinase Activity That Correlates with Enhanced Cellular Proliferation in Fibroblasts from Rat Pulmonary But Not Systemic Arteries

DAVID J. WELSH, ANDREW J. PEACOCK, MARGARET MacLEAN, and MARGARET HARNETT

Scottish Pulmonary Vascular Unit and Department of Immunology, Western Infirmary; and Institute of Biomedical and Life Sciences, University of Glasgow, Glasgow, Scotland, United Kingdom

Pulmonary hypertension occurs commonly in patients with chronic hypoxic lung disease and is characterized by the remodeling of the pulmonary artery walls. The molecular mechanisms underlying such remodeling are unknown but we have recently shown that the stress-activated (Jnk and p38) mitogen-activated protein (MAP) kinases are activated in pulmonary artery fibroblasts following acute hypoxia. We now show that Erk and p38 MAP kinases are constitutively activated in fibroblasts derived from the remodeled pulmonary, but not the systemic circulation from rats exposed to chronically hypoxic conditions. Moreover, we find that such fibroblasts show sustained enhanced proliferative capacities relative to pulmonary artery fibroblasts derived from normoxic rats or to aortic fibroblasts from either normoxic or hypoxic rats. Finally, abrogation of p38, but not Erk MAP kinase activity by use of specific inhibitors, prevents the enhanced proliferative capacity exhibited by pulmonary artery fibroblasts. Taken together, these data suggest that enhanced p38 MAP kinase activity provides a molecular mechanism to explain the proliferation of pulmonary artery fibroblasts required for remodeling of the pulmonary vasculature.




This article has been cited by other articles:


Home page
 Physiol. GenomicsHome page
L. Moreno-Vinasco, M. Gomberg-Maitland, M. L. Maitland, A. A. Desai, P. A. Singleton, S. Sammani, L. Sam, Y. Liu, A. N. Husain, R. M. Lang, et al.
Genomic assessment of a multikinase inhibitor, sorafenib, in a rodent model of pulmonary hypertension
Physiol Genomics, April 21, 2008; 33(2): 278 - 291.
[Abstract] [Full Text] [PDF]

Home page
 Cardiovasc ResHome page
M. Das, N. Burns, S. J. Wilson, W. M. Zawada, and K. R. Stenmark
Hypoxia exposure induces the emergence of fibroblasts lacking replication repressor signals of PKC{zeta} in the pulmonary artery adventitia
Cardiovasc Res, February 22, 2008; (2008) cvn014v2.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Cell Mol. Bio.Home page
C. M. Carlin, A. J. Peacock, and D. J. Welsh
Fluvastatin Inhibits Hypoxic Proliferation and p38 MAPK Activity in Pulmonary Artery Fibroblasts
Am. J. Respir. Cell Mol. Biol., October 1, 2007; 37(4): 447 - 456.
[Abstract] [Full Text] [PDF]

Home page
 Eur Respir JHome page
O. Pak, A. Aldashev, D. Welsh, and A. Peacock
The effects of hypoxia on the cells of the pulmonary vasculature
Eur. Respir. J., August 1, 2007; 30(2): 364 - 372.
[Abstract] [Full Text] [PDF]

Home page
 Circ. Res.Home page
K. R. Stenmark, K. A. Fagan, and M. G. Frid
Hypoxia-Induced Pulmonary Vascular Remodeling: Cellular and Molecular Mechanisms
Circ. Res., September 29, 2006; 99(7): 675 - 691.
[Abstract] [Full Text] [PDF]

Home page
 PhysiologyHome page
K. R. Stenmark, N. Davie, M. Frid, E. Gerasimovskaya, and M. Das
Role of the Adventitia in Pulmonary Vascular Remodeling
Physiology, April 1, 2006; 21(2): 134 - 145.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
H. Takahashi, N. Goto, Y. Kojima, Y. Tsuda, Y. Morio, M. Muramatsu, and Y. Fukuchi
Downregulation of type II bone morphogenetic protein receptor in hypoxic pulmonary hypertension
Am J Physiol Lung Cell Mol Physiol, March 1, 2006; 290(3): L450 - L458.
[Abstract] [Full Text] [PDF]

Home page
 ChestHome page
D. Welsh, H. Mortimer, A. Kirk, and A. Peacock
The Role of p38 Mitogen-Activated Protein Kinase in Hypoxia-Induced Vascular Cell Proliferation: An Interspecies Comparison
Chest, December 1, 2005; 128(6_suppl): 573S - 574S.
[Full Text] [PDF]

Home page
 J. Thorac. Cardiovasc. Surg.Home page
J. Lu, H. Shimpo, A. Shimamoto, A. J. Chong, C. R. Hampton, D. J. Spring, M. Yada, M. Takao, K. Onoda, I. Yada, et al.
Specific inhibition of p38 mitogen-activated protein kinase with FR167653 attenuates vascular proliferation in monocrotaline-induced pulmonary hypertension in rats
J. Thorac. Cardiovasc. Surg., December 1, 2004; 128(6): 850 - 859.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
K. K. K. Sheares, T. K. Jeffery, L. Long, X. Yang, and N. W. Morrell
Differential effects of TGF-{beta}1 and BMP-4 on the hypoxic induction of cyclooxygenase-2 in human pulmonary artery smooth muscle cells
Am J Physiol Lung Cell Mol Physiol, November 1, 2004; 287(5): L919 - L927.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
R. Naeije and S. Eddahibi
Serotonin in Pulmonary Arterial Hypertension
Am. J. Respir. Crit. Care Med., August 1, 2004; 170(3): 209 - 210.
[Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
D. J. Welsh, M. Harnett, M. MacLean, and A. J. Peacock
Proliferation and Signaling in Fibroblasts: Role of 5-Hydroxytryptamine2A Receptor and Transporter
Am. J. Respir. Crit. Care Med., August 1, 2004; 170(3): 252 - 259.
[Abstract] [Full Text] [PDF]

Home page
 J. Appl. Physiol.Home page
A. Cogo, G. Napolitano, M. C. Michoud, D. R. Barbon, M. Ward, and J. G. Martin
Effects of hypoxia on rat airway smooth muscle cell proliferation
J Appl Physiol, April 1, 2003; 94(4): 1403 - 1409.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
M. Ruchko, M. N. Gillespie, R. S. Weeks, J. W. Olson, and P. Babal
Putrescine transport in hypoxic rat main PASMCs is required for p38 MAP kinase activation
Am J Physiol Lung Cell Mol Physiol, January 1, 2003; 284(1): L179 - L186.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Cell Mol. Bio.Home page
X. Yang, K. K. K. Sheares, N. Davie, P. D. Upton, G. W. Taylor, J. Horsley, J. Wharton, and N. W. Morrell
Hypoxic Induction of Cox-2 Regulates Proliferation of Human Pulmonary Artery Smooth Muscle Cells
Am. J. Respir. Cell Mol. Biol., December 1, 2002; 27(6): 688 - 696.
[Abstract] [Full Text] [PDF]

Home page
 ChestHome page
K. R. Stenmark, E. Gerasimovskaya, R. A. Nemenoff, and M. Das
Hypoxic Activation of Adventitial Fibroblasts: Role in Vascular Remodeling
Chest, December 1, 2002; 122(6_suppl): 326S - 334S.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
U. S. Kayyali, C. M. Pennella, C. Trujillo, O. Villa, M. Gaestel, and P. M. Hassoun
Cytoskeletal Changes in Hypoxic Pulmonary Endothelial Cells Are Dependent on MAPK-activated Protein Kinase MK2
J. Biol. Chem., November 1, 2002; 277(45): 42596 - 42602.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
M. J. TOBIN
Chronic Obstructive Pulmonary Disease, Pollution, Pulmonary Vascular Disease, Transplantation, Pleural Disease, and Lung Cancer in AJRCCM 2001
Am. J. Respir. Crit. Care Med., March 1, 2002; 165(5): 642 - 662.
[Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Proc. Am. Thorac. Soc. Am. J. Respir. Cell Mol. Biol.
Copyright © 2001 American Thoracic Society